Canadian Ebola vaccine to be tested in Europe, Gabon, Kenya

LONDON, Oct 29 (Reuters) - Trials of an experimental vaccine developed by the Canadian government and licensed to NewLink Genetics will begin swiftly in healthy volunteers in Europe, Gabon and Kenya, under a programme with funding from the Wellcome Trust.